Study of the safety and effects of gepotidacin in children aged 2 to 12 years with bacterial infections such as urinary tract infections
- Substances:–
Poland- Participants:0–17 years
Rare diseases
Investigational molecules
Locations
PolandA study to evaluate the safety and effectiveness of filgotinib in children and adolescents aged 8 to 17 years with polyarticular juvenile idiopathic arthritis
PolandA study to evaluate the safety and effectiveness of filgotinib in children and adolescents with juvenile idiopathic arthritis.
PolandA study to evaluate the effectiveness and safety of LAD328 in adults with moderate to severe hidradenitis suppurativa
PolandComparing sotorasib and pembrolizumab with chemotherapy for patients with advanced non-small cell lung cancer and a KRAS G12C mutation
PolandStudy to evaluate the effect of omaveloxolone on mitochondrial function in patients with Friedreich's ataxia
PolandA study to evaluate the effects of zenagamtide in people with overweight or obesity and obstructive sleep apnoea not treated with positive airway pressure
PolandA study to evaluate the effectiveness of NAV-240 in adults with moderate-to-severe hidradenitis suppurativa
PolandStudy of zenagamtide for weight loss and sleep improvement in patients with obesity and obstructive sleep apnea using positive airway pressure therapy
PolandA study of rilvegostomig, cisplatin, and gemcitabine compared to durvalumab and a drug combination for adults with advanced biliary tract cancer
PolandA study of mRNA-4157 and a drug combination for patients with stage IV non-small cell lung cancer
PolandA study to evaluate the safety and effectiveness of KPL-387 in patients with well-controlled recurrent pericarditis
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.